These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24399716)

  • 1. Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
    Saitoh K; Abe K; Chiba T; Katagiri N; Saitoh T; Horiguchi Y; Nojima H; Taguchi K
    Pharmacol Rep; 2013; 65(5):1204-12. PubMed ID: 24399716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
    Munakata H; Ishikawa R; Saitoh T; Kambe T; Chiba T; Taguchi K; Abe K
    Can J Physiol Pharmacol; 2022 Jul; 100(7):594-611. PubMed ID: 35413210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice.
    Katagiri N; Chida S; Abe K; Nojima H; Kitabatake M; Hoshi K; Horiguchi Y; Taguchi K
    Brain Res; 2010 Mar; 1321():133-42. PubMed ID: 20114039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
    Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
    J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1-cyclohexyl- and 1-cyclohexyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats.
    Abe M; Munakata H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
    Brain Res Bull; 2016 Mar; 121():201-8. PubMed ID: 26876935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1,2,3,4-tetrahydroisoquinoline derivatives on dopaminergic spontaneous discharge in substantia nigra neurons in rats.
    Chiba H; Sato H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
    Pharmacology; 2015; 95(1-2):87-94. PubMed ID: 25633935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.
    Tasaki Y; Makino Y; Ohta S; Hirobe M
    J Neurochem; 1991 Dec; 57(6):1940-3. PubMed ID: 1940911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of chiral 3-methyl- and 3-methyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline and prevention of MPP+ -induced cytotoxicity.
    Saitoh T; Yamashita A; Abe K; Ogawa K; Kitabatake M; Taguchi K; Horiguchi Y
    Med Chem; 2008 Nov; 4(6):531-8. PubMed ID: 18991736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway.
    Zheng M; Liu C; Fan Y; Shi D; Jian W
    J Ethnopharmacol; 2019 Dec; 245():112182. PubMed ID: 31445131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
    J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
    Teismann P; Ferger B
    Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
    Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD
    Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.